Continuous Glucose Monitoring Sensors: Past, Present and Future Algorithmic Challenges
Open accessThe DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
Abstract
Continuous glucose monitoring (CGM) sensors are portable devices that allow measuring and visualizing the glucose concentration in real time almost continuously for several days and are provided with hypo/hyperglycemic alerts and glucose trend information. CGM sensors have revolutionized Type 1 diabetes (T1D) management, improving glucose control when used adjunctively to self-monitoring blood glucose systems. Furthermore, CGM devices have stimulated the development of applications that were impossible to create without a continuous-time glucose signal, e.g., real-time predictive alerts of hypo/hyperglycemic episodes based on the prediction of future glucose concentration, automatic basal insulin attenuation methods for hypoglycemia prevention, and the artificial pancreas. However, CGM sensors’ lack of accuracy and reliability limited their usability in the clinical practice, calling upon the academic community for the development of suitable signal processing methods to improve CGM performance. The aim of this paper is to review the past and present algorithmic challenges of CGM sensors, to show how they have been tackled by our research group, and to identify the possible future ones.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 The smart CGM sensor architecture, which consists of placing, in cascade to the output of a commercial CGM sensor, three software modules, able to work in real time, for denoising the random noise component, enhancing the accuracy, and predicting the future glucose concentration (adapted from [27]).](https://figures.cochat.ai/paper-figures/c1dcdb45c40842afa0dbc799604b1883/continuous-glucose-monitoring-sensors-past-present-and-future-algorithmic-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The accuracy of CGM devices has improved significantly over time, with manufacturers of current devices reporting mean absolute relative deviation (MARD) proportions of 8.1% to 12.3%, compared with 5% to 10% for current BGM devices (and 22% for the first intermittently read interstitial glucose monitor brought to market in 2001) (190).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [190]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
The UVA/PADOVA Type 1 Diabetes Simulator: New Features
Man, C. D., Micheletto, F., Lv, D., Breton, M., Kovatchev, B., & Cobelli, C. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813514502 · Cited by 791 · cited 1×
“The UVA/Padova T1D simulator is a large-scale maximal computer model of glucose, insulin and glucagon dynamics in patients with T1D, described by 13 differential equations and provided with three different populations: 100 adult, 100 pediatric and 100 adolescent virtual subjects [52,53].”
BackgroundIn Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes
Kovatchev, B. P., Breton, M., Dalla Man, C., & Cobelli, C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300106 · Cited by 760 · cited 1×
“The UVA/Padova T1D simulator is a large-scale maximal computer model of glucose, insulin and glucagon dynamics in patients with T1D, described by 13 differential equations and provided with three different populations: 100 adult, 100 pediatric and 100 adolescent virtual subjects [52,53].”
BackgroundThe Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685 · cited 1×
“The reduction/elimination of calibrations in CGM systems is further pressured by the recent advent of the Abbott Freestyle Libre (Abbott Diabetes Care, Alameda, CA, USA) [62,63].”
MethodSparacino, G., Zanderigo, F., Corazza, S., Maran, A., Facchinetti, A., & Cobelli, C. (2007) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2006.889774 · Cited by 338 · cited 1×
“Finally, the algorithm we employed in the prediction module is a simple but effective predictor based on an autoregressive model of order one [40], whose key feature is the real-time estimation of the predictor’s parameters using a recursive least squares implementation, exploiting a forgetting…”
MethodSelf-citationPerformance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home Use
Gross, T. M., Bode, B. W., Einhorn, D., Kayne, D. M., Reed, J. H., White, N. H., & Mastrototaro, J. J. (2000) · Diabetes Technology & Therapeutics · doi:10.1089/152091500316737 · Cited by 303
Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose Monitoring
Kovatchev, B. P., Patek, S. D., Ortiz, E. A., & Breton, M. D. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0272 · Cited by 234 · cited 2×
“Only Kovatchev et al. [47] explicitly addressed this problem and tried to give some indications on this topic.”
BackgroundComing of age: the artificial pancreas for type 1 diabetes
Thabit, H., & Hovorka, R. (2016) · Diabetologia · doi:10.1007/s00125-016-4022-4 · Cited by 223
Georga, E. I., Protopappas, V. C., Ardigo, D., Marina, M., Zavaroni, I., Polyzos, D., & Fotiadis, D. I. (2013) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/titb.2012.2219876 · Cited by 216 · cited 1×
“…can be employed, e.g., those of Zhao et al. [9,12], Zecchin et al. [13,41], Turksoy et al. [10], Zarkogianni et al. [11], and Georga et al. [42,43] The algorithmically “smart” CGM sensor concept has been validated on a dataset consisting of 23 T1D individuals whose glucose concentrations…”
Method
Cited by
Electrochemical glucose sensors in diabetes management: an updated review (2010–2020)
Teymourian, H., Barfidokht, A., & Wang, J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00304b · Cited by 881
Villena Gonzales, W., Mobashsher, A., & Abbosh, A. (2019) · Sensors · doi:10.3390/s19040800 · Cited by 772
“As a result, these and many other unsuccessful outcomes have left many wondering if it is possible to measure glucose in a way that doesn’t need any blood drawn out of the body.”
BackgroundMethodCappon, G., Vettoretti, M., Sparacino, G., & Facchinetti, A. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0121 · Cited by 477
Self-citationWearable Electrochemical Glucose Sensors in Diabetes Management: A Comprehensive Review
Saha, T., Del Caño, R., Mahato, K., De la Paz, E., Chen, C., Ding, S., Yin, L., & Wang, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00078 · Cited by 442
Wearable Electrochemical Sensors for the Monitoring and Screening of Drugs
Teymourian, H., Parrilla, M., Sempionatto, J. R., Montiel, N. F., Barfidokht, A., Van Echelpoel, R., De Wael, K., & Wang, J. (2020) · ACS Sensors · doi:10.1021/acssensors.0c01318 · Cited by 423
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Convolutional Recurrent Neural Networks for Glucose Prediction
Li, K., Daniels, J., Liu, C., Herrero, P., & Georgiou, P. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2019.2908488 · Cited by 310
“This approach has proven to be effective in controlling BG and thus improving the outcome of subjects in clinical trials [6].”
BackgroundLee, I., Probst, D., Klonoff, D., & Sode, K. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113054 · Cited by 288
Advances in technology for management of type 1 diabetes
Beck, R. W., Bergenstal, R. M., Laffel, L. M., & Pickup, J. C. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31142-0 · Cited by 242
Wearable Continuous Glucose Monitoring Sensors: A Revolution in Diabetes Treatment
Cappon, G., Acciaroli, G., Vettoretti, M., Facchinetti, A., & Sparacino, G. (2017) · Electronics · doi:10.3390/electronics6030065 · Cited by 237
“From the technological point of view, examples of research activities include the exploration of principles alternative to glucose‐oxidase, such as fluorescence and skin dielectric properties [14], ergonomics [15], data/signal processing [16], and software development [17] to mention a few.”
BackgroundSelf-citationDeSalvo, D. J., Miller, K. M., Hermann, J. M., Maahs, D. M., Hofer, S. E., Clements, M. A., Lilienthal, E., Sherr, J. L., Tauschmann, M., Holl, R. W., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12711 · Cited by 233
GluNet: A Deep Learning Framework for Accurate Glucose Forecasting
Li, K., Liu, C., Zhu, T., Herrero, P., & Georgiou, P. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2019.2931842 · Cited by 206
“It has been proven that CGM technology helps T1D subjects to have a better glycemic control [3], [4] by alerting them when hypo-or hyperglycemia events occur [5]–[7].”
BackgroundShah, V. N., Laffel, L. M., Wadwa, R. P., & Garg, S. K. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0143 · Cited by 197
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 206
Christiansen, M. P., Klaff, L. J., Brazg, R., Chang, A. R., Levy, C. J., Lam, D., Denham, D. S., Atiee, G., Bode, B. W., Walters, S. J., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0142 · Cited by 146
Fernández-Caramés, T. M., Froiz-Míguez, I., Blanco-Novoa, O., & Fraga-Lamas, P. (2019) · Sensors · doi:10.3390/s19153319 · Cited by 146
Noninvasive Blood Glucose Monitoring Systems Using Near-Infrared Technology—A Review
Hina, A., & Saadeh, W. (2022) · Sensors · doi:10.3390/s22134855 · Cited by 179
Saifullah, K. M., & Rad, Z. F. (2023) · Advanced Materials Interfaces · doi:10.1002/admi.202201763 · Cited by 148
A pilot study in humans of microneedle sensor arrays for continuous glucose monitoring
Sharma, S., El-Laboudi, A., Reddy, M., Jugnee, N., Sivasubramaniyam, S., El Sharkawy, M., Georgiou, P., Johnston, D., Oliver, N., & Cass, A. E. G. (2018) · Analytical Methods · doi:10.1039/c8ay00264a · Cited by 123
Identifiability analysis for stochastic differential equation models in systems biology
Browning, A. P., Warne, D. J., Burrage, K., Baker, R. E., & Simpson, M. J. (2020) · Journal of The Royal Society Interface · doi:10.1098/rsif.2020.0652 · Cited by 143
Scholten, K., & Meng, E. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.02.022 · Cited by 102
Yoo, J. H., Choi, M. S., Ahn, J., Park, S. W., Kim, Y., Hur, K. Y., Jin, S.-M., Kim, G., & Kim, J. H. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0499 · Cited by 98
How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?
Ajjan, R. A. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0021 · Cited by 97
A Study about Kalman Filters Applied to Embedded Sensors
Valade, A., Acco, P., Grabolosa, P., & Fourniols, J.-Y. (2017) · Sensors · doi:10.3390/s17122810 · Cited by 90
“One of these applications is automatic and continuous sensor calibration [5] with correction over time.”
BackgroundAlShorman, O., AlShorman, B., Al-khassaweneh, M., & Alkahtani, F. (2020) · Indonesian Journal of Electrical Engineering and Computer Science · doi:10.11591/ijeecs.v20.i1.pp414-422 · Cited by 84
“[72] Continuous glucose monitoring sensors Continuous glucose monitoring sensor Past and present algorithmic challenges of Continuous”
BackgroundPrediction of Adverse Glycemic Events From Continuous Glucose Monitoring Signal
Gadaleta, M., Facchinetti, A., Grisan, E., & Rossi, M. (2018) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2018.2823763 · Cited by 77
“However, avoiding hypoglycemic and hyperglycemic events, or at least mitigating their frequency and duration, still remains an open challenge [5].”
Self-citationGlucose Concentration Measurement in Human Blood Plasma Solutions with Microwave Sensors
Juan, C. G., Bronchalo, E., Potelon, B., Quendo, C., & Sabater-Navarro, J. M. (2019) · Sensors · doi:10.3390/s19173779 · Cited by 65
Cappon, G., Vettoretti, M., Marturano, F., Facchinetti, A., & Sparacino, G. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818759558 · Cited by 62
Self-citationMoser, O., Yardley, J. E., & Bracken, R. M. (2018) · Nutrients · doi:10.3390/nu10010093 · Cited by 67
Boscari, F., & Avogaro, A. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09635-3 · Cited by 80
Continuous glucose monitoring and intrapersonal variability in fasting glucose
Shilo, S., Keshet, A., Rossman, H., Godneva, A., Talmor‐Barkan, Y., Aviv, Y., & Segal, E. (2024) · Nature Medicine · doi:10.1038/s41591-024-02908-9 · Cited by 253
“Current CGM devices report mean absolute relative deviation percentages ranging from 8.1% to 12.3%, overlapping with the 5–10% range for BGM devices 11 .”
InfluentialClinical Implications of Accuracy Measurements of Continuous Glucose Sensors
Bailey, T. S. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0050 · Cited by 60
“25 The recent approval of Dexcom’s G5 CGM for nonadjuctive use was largely based on both its lower MARD and two in silico simulations.”
InfluentialLi, J., Igbe, T., Liu, Y., Nie, Z., Qin, W., Wang, L., & Hao, Y. (2018) · IEEE Access · doi:10.1109/access.2018.2866601 · Cited by 61
Rooney, N. J., Guest, C., Swanson, L. C. M., & Morant, S. V. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210092 · Cited by 58
Yin, H., Mukadam, B., Dai, X., & Jha, N. K. (2019) · IEEE Transactions on Emerging Topics in Computing · doi:10.1109/tetc.2019.2958946 · Cited by 61
Forlenza, G. P., Kushner, T., Messer, L. H., Wadwa, R. P., & Sankaranarayanan, S. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0401 · Cited by 63
Ajagbe, S. A., Awotunde, J. B., Adesina, A. O., Achimugu, P., & Kumar, T. A. (2022) · Springer eBooks · doi:10.1007/978-981-16-8150-9_14 · Cited by 69
An IoT-Based Glucose Monitoring Algorithm to Prevent Diabetes Complications
Valenzuela, F., Garcia-Berumen, A., Ruiz, E., Vázquez, M., Cortez, J., & Espinoza, A. (2020) · Applied Sciences · doi:10.3390/app10030921 · Cited by 49
An autonomous channel deep learning framework for blood glucose prediction
Yang, T., Yu, X., Ma, N., Wu, R., & Li, H. (2022) · Applied Soft Computing · doi:10.1016/j.asoc.2022.108636 · Cited by 56
Fault and meal detection by redundant continuous glucose monitors and the unscented Kalman filter
Mahmoudi, Z., Nørgaard, K., Poulsen, N. K., Madsen, H., & Jørgensen, J. B. (2017) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2017.05.004 · Cited by 53
Fernández‐Caramés, T. M., & Fraga‐Lamas, P. (2018) · International Electronic Conference on Sensors and Applications (ECSA) · doi:10.3390/ecsa-5-05757 · Cited by 59
“The same authors focused, later, on the same concepts in another paper that reviews the state of the art on contributions to the development of hardware and smart algorithms for CGMs [8].”
BackgroundGluGAN: Generating Personalized Glucose Time Series Using Generative Adversarial Networks
Zhu, T., Li, K., Herrero, P., & Georgiou, P. (2023) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2023.3271615 · Cited by 56
Forlenza, G. P., Messer, L. H., Berget, C., Wadwa, R. P., & Driscoll, K. A. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1078-1 · Cited by 42
Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes
Ramli, R., Reddy, M., & Oliver, N. S. (2019) · Drugs · doi:10.1007/s40265-019-01149-2 · Cited by 48
Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown
Boscari, F., Ferretto, S., Uliana, A., Avogaro, A., & Bruttomesso, D. (2021) · Nutrition & Diabetes · doi:10.1038/s41387-020-00147-8 · Cited by 39
“Sensors 16, 2093 (2016).”
Acciaroli, G., Vettoretti, M., Facchinetti, A., Sparacino, G., & Cobelli, C. (2018) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2017.2706974 · Cited by 36
“used to make daily diabetes treatment decisions without finger pricking [16], [17] (see http://www.”
MethodSelf-citationNanopatterned Bulk Metallic Glass Biosensors
Kinser, E. R., Padmanabhan, J., Yu, R., Corona, S. L., Li, J., Vaddiraju, S., Legassey, A., Loye, A. M., Balestrini, J. L., Solly, D. A., et al. (2017) · ACS Sensors · doi:10.1021/acssensors.7b00455 · Cited by 36
Faccioli, S., Del Favero, S., Visentin, R., Bonfanti, R., Iafusco, D., Rabbone, I., Marigliano, M., Schiaffini, R., Bruttomesso, D., Cobelli, C., et al. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817706377 · Cited by 31
Li, N., Tuo, J., Wang, Y., & Wang, M. (2019) · Neurocomputing · doi:10.1016/j.neucom.2019.10.003 · Cited by 33
Zanon, M., Mueller, M., Zakharov, P., Talary, M. S., Donath, M. Y., Stahel, W. A., & Caduff, A. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817740591 · Cited by 32
Diabetes Technology Trends: A Review of the Latest Innovations
Lundgrin, E. L., Kelly, C. A., Bellini, N. J., Lewis, C. J., Rafi, E., & Hatipoğlu, B. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf034 · Cited by 38
Modeling of Diabetes and Its Clinical Impact
Fritzen, K., Heinemann, L., & Schnell, O. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818785642 · Cited by 34
Rodríguez‐Rodríguez, I., Rodríguez, J., & Zamora, M. Á. (2018) · Journal of Diabetes Research · doi:10.1155/2018/4826984 · Cited by 31
“Denoising, enhancement of raw data accuracy, and minimizing error due to the delay introducing a correction are the three main key challenges [15].”
BackgroundCalibration algorithms for continuous glucose monitoring systems based on interstitial fluid sensing
Sun, T., Liu, J., & Chen, C. J. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116450 · Cited by 34
Boscari, F., Vettoretti, M., Cavallin, F., Amato, A. M. L., Uliana, A., Vallone, V., Avogaro, A., Facchinetti, A., & Bruttomesso, D. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01624-2 · Cited by 33
Self-citationMartin, C., Criego, A. B., Carlson, A. L., & Bergenstal, R. M. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1177-7 · Cited by 34
A Modular Safety System for an Insulin Dose Recommender: A Feasibility Study
Liu, C., Avari, P., Leal, Y., Wos, M., Sivasithamparam, K., Georgiou, P., Reddy, M., Fernández-Real, J., Martin, C. E., Fernández-Balsells, M., et al. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819851135 · Cited by 25
Larose, S., RABASA-LHORET, R. P. R., Roy‐Fleming, A., Suppère, C., Tagougui, S., Messier, V., & Taleb, N. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0400 · Cited by 31
Ghoreishizadeh, S. S., Zhang, X., Sharma, S., & Georgiou, P. (2017) · IEEE Sensors Letters · doi:10.1109/lsens.2017.2778248 · Cited by 28
“A notable example that is commercially available is continuous glucose measurement (CGM) device that uses enzymatic electrochemical glucose sensor for management of diabetes [3].”
BackgroundLu, Y., Liu, D., Liang, Z., Liu, R., Chen, P., Liu, Y., Li, J., Feng, Z., Li, L. M., Sheng, B., et al. (2025) · National Science Review · doi:10.1093/nsr/nwaf039 · Cited by 46
A review of wearable sensors based monitoring with daily physical activity to manage type 2 diabetes
AlShorman, O., Alshorman, B., & Alkahtani, F. (2020) · International Journal of Power Electronics and Drive Systems/International Journal of Electrical and Computer Engineering · doi:10.11591/ijece.v11i1.pp646-653 · Cited by 26
“CHALLENGES This section summarizes challenges and future trends for wearable sensors based monitoring with daily physical activity to manage type 2 diabetes, including [101, 102, 112-114]: - PA level: yet, there is a lack of clarity about what level of PA is needed to reduce the risk of T2D.”
BackgroundNafion based biosensors: a review of recent advances and applications
Kakhki, R. M. (2023) · International Journal of Polymeric Materials · doi:10.1080/00914037.2023.2297436 · Cited by 25
“There are different kinds of devices that can measure glucose continuously, but only a few of them are available for sale [41, 42] .”
Modeling the Error of the Medtronic Paradigm Veo Enlite Glucose Sensor
Biagi, L., Ramkissoon, C. M., Facchinetti, A., Leal, Y., & Vehí, J. (2017) · Sensors · doi:10.3390/s17061361 · Cited by 27
“Finally, as recently seen with the Dexcom G5 Mobile sensor (San Diego, CA, USA), the availability of a detailed model of CGM sensor error allows specific sensors to be tested in silico [13] to determine if they can be safe and effective for non-adjunctive therapeutics decisions, i.”
MethodSelf-citationYeoh, E. C. K., Png, D., Khoo, J., Chee, Y. J., Sharda, P., Low, S. K., Lim, S. C., & Subramaniam, T. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3560 · Cited by 25
Applications of the Internet of Medical Things to Type 1 Diabetes Mellitus
Rodríguez‐Rodríguez, I., Rodríguez, J., & Campo-Valera, M. (2023) · Electronics · doi:10.3390/electronics12030756 · Cited by 31
Cappon, G., Facchinetti, A., Sparacino, G., Georgiou, P., & Herrero, P. (2019) · Sensors · doi:10.3390/s19143168 · Cited by 29
“, carbohydrate counting) can be used to develop new algorithms aimed at improving standard insulin therapy [33,34].”
BackgroundSelf-citationAccuracy of CGM Systems During Continuous and Interval Exercise in Adults with Type 1 Diabetes
Prato, G. D., Pasquini, S., Rinaldi, E., Lucianer, T., Donà, S., Santi, L., Negri, C., Bonora, E., Moghetti, P., & Trombetta, M. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211023522 · Cited by 26
On the use of fiber lasers in non-invasive blood glucose monitoring
Peng, X., Yan, Y., & Liu, H. (2022) · Optical Fiber Technology · doi:10.1016/j.yofte.2022.102822 · Cited by 28
Clinically Accurate Prediction of Glucose Levels in Patients with Type 1 Diabetes
Amar, Y., Shilo, S., Oron, T., Amar, E., Phillip, M., & Segal, E. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0435 · Cited by 27
Naveena, S., & Bharathi, A. (2022) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2022.103748 · Cited by 28
In vivo continuous monitoring of peptides and proteins: Challenges and opportunities
Wilson, E. D., Probst, D., & Sode, K. (2023) · Applied Physics Reviews · doi:10.1063/5.0154637 · Cited by 24
Acciaroli, G., Vettoretti, M., Facchinetti, A., & Sparacino, G. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0297 · Cited by 22
“Even if a nonadjunctive use of CGM, that is, treatment decisions can be made without finger pricking, has been recently approved by the U.S. Food and Drug Administration, 12–14 SMBG samples are still required for calibration purposes twice a day, forcing CGM users to carry both devices with them.”
Self-citationLundemose, S. B., Laugesen, C., Ranjan, A. G., & Nørgaard, K. (2023) · Sensors · doi:10.3390/s23229256 · Cited by 21
“This electric current is then transmitted to a receiver or monitor, providing a rich stream of glucose readings [2,3].”
Dávila-Rúales, V., Córdoba, L. F. G., Medina, A. M. G., Múñoz, Ó., Serrano, M. N., & Henao, D. C. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241304459 · Cited by 22
Lü, X., Wei, H., Yang, C., Li, Q., Li, P. S., Chen, J., Sun, Y., Wen, H., Jiang, M., & Wang, G. (2021) · Aquaculture Reports · doi:10.1016/j.aqrep.2021.100964 · Cited by 19
Non-invasive Blood Glucose Monitoring and Data Analytics
Eadie, M., & Steele, R. J. (2017) · International Conference on Compute and Data Analysis (ICCDA) · doi:10.1145/3093241.3093283 · Cited by 18
“While CGM sensors are known to have been less accurate and reliable than finger stick approaches over the preceding few decades [3], more recent incremental improvements including the adoption of greater algorithmic signal processing and analytic techniques have removed that comparative accuracy gap with CGM approache…”
BackgroundMethodInfluentialKim, Y.-I., Choi, Y., & Park, J. (2023) · Physical Activity and Nutrition · doi:10.20463/pan.2023.0028 · Cited by 25
“Technical issues with CGM devices, such as sensor failure or synchronization, can disrupt data collection and affect usabili - ty 100,101 .”
BackgroundHochfellner, D. A., Simic, A., Taucher, M. T., Sailer, L. S., Kopanz, J., Pöttler, T., & Mader, J. K. (2022) · Biosensors · doi:10.3390/bios12020106 · Cited by 15
Kalita, D., Sharma, H., Panda, J. K., & Mirza, K. B. (2024) · Medical Engineering & Physics · doi:10.1016/j.medengphy.2024.104241 · Cited by 20
Diabetes Management Experience and the State of Hypoglycemia: National Online Survey Study
Zahed, K., Sasangohar, F., Mehta, R. K., Erraguntla, M., & Qaraqe, K. A. (2020) · JMIR Diabetes · doi:10.2196/17890 · Cited by 16
“However, these tools are invasive and costly and require regular maintenance and calibration [12].”
Comparing the accuracy of transcutaneous sensor and 90-day implantable glucose sensor
Boscari, F., Vettoretti, M., Amato, A. M. L., Vallone, V., Uliana, A., Iori, E., Avogaro, A., Facchinetti, A., & Bruttomesso, D. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.09.006 · Cited by 15
Self-citationRole of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes
Welsh, J. B. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0100 · Cited by 17
“In the decade since publication of the JDRF CGM study, 4 CGM accuracy has improved 5 and its use has increased dramatically among youth and young adults with T1D, 6 but is still low.”
Rubelj, K. (2021) · Acta Clinica Croatica · doi:10.20471/acc.2021.60.04.07 · Cited by 13
Recent advances in the precision control strategy of artificial pancreas
Ming, W., Guo, X., Zhang, G., Liu, Y., Wang, Y., Zhang, H., Liang, H., & Yang, Y. (2024) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-024-03042-x · Cited by 17
“In addition, the delay in the action of insulin and the lag in obtaining BG information from BG sensors make hypoglycemia prone to external interference [24, 25].”
Zeng, N., Li, J., Igbe, T., Liu, Y., Yan, C. H., & Nie, Z. (2018) · IEEE International Conference on e-Health Networking, Applications and Services (Healthcom) · doi:10.1109/healthcom.2018.8531182 · Cited by 12
“Numerous researches attempt to achieve NBGM by researching the effects of blood glucose concentration on electrical signals[5].”
BackgroundSopfe, J., Vigers, T., Pyle, L. L., Giller, R., & Forlenza, G. P. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0521 · Cited by 12
Meng, R., Gu, T., Yang, F., Liu, J., Sun, Q., & Zhu, D. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01171-2 · Cited by 11
AWD-stacking: An enhanced ensemble learning model for predicting glucose levels
Yang, H., Chen, Z., Huang, J., & Li, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0291594 · Cited by 22
Jia, Z., Huang, L., Liu, H., Huang, Y., Li, W., Pi, X., & Zheng, X. (2019) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-019-03142-7 · Cited by 11
“The aim of denoising module is to use the digital filters to reduce the uncertainty caused by sampling and measurement error [23, 32].”
BackgroundMethodTian, J., Peng, D., Wen, H., Wang, G., Li, P. S., Chen, J., Sun, Y., Lü, X., Wu, F., & Li, Q. (2020) · Aquaculture Nutrition · doi:10.1111/anu.13056 · Cited by 11
Personalized Dual-Hormone Control for Type 1 Diabetes Using Deep Reinforcement Learning
Zhu, T., Li, K., & Georgiou, P. (2020) · Studies in computational intelligence · doi:10.1007/978-3-030-53352-6_5 · Cited by 14
“Many algorithms are developed and verified as closed-loop single/dual hormone delivery strategies (Bergenstal et al. 2016) that are mostly based on control algorithms (Facchinetti 2016; Haidar 2016).”
Mendez, C., Kaykayoglu, C. A., Bähler, T., Künzler, J., Lizoain, A., Rothenbühler, M., Schmidt, M. H., Laimer, M., & Witthauer, L. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251319800 · Cited by 10
“19,20 The latter is problematic during sleep, as false hypoglycemia alarms disrupt sleep.”
Model predictive control with event-triggered communication for an embedded artificial pancreas
Chakrabarty, A., Zavitsanou, S., Doyle, F. J., & Dassau, E. (2017) · IEEE Conference on Control Technology and Applications (CCTA) · doi:10.1109/ccta.2017.8062517 · Cited by 11
“Recent advances in CGM technology and signal processing methods have greatly improved the accuracy of sensing, resulting in better clinical management of type 1 diabetes; see for example, [2]–[4].”
MethodKoutný, T., & Úbl, M. (2020) · Procedia Computer Science · doi:10.1016/j.procs.2020.10.048 · Cited by 10
“A sophisticated computer algorithm may be a solution, when directly controlling the insulin pump [9].”
BackgroundLS-GRUNet: Glucose Forecasting Using Deep Learning for Closed-loop Diabetes Management
Kalita, D., & Mirza, K. B. (2022) · IEEE International Conference for Convergence in Technology (I2CT) · doi:10.1109/i2ct54291.2022.9824867 · Cited by 13
A Dual-Hormone Closed-Loop Delivery System for Type 1 Diabetes Using Deep Reinforcement LearningPreprint
Zhu, T., Li, K., & Georgiou, P. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1910.04059 · Cited by 14
“Many algorithms are developed and verified as closed-loop single/dual hormone delivery strategies [13] that are mostly based on control algorithms [14, 15].”
Kalita, D., & Mirza, K. B. (2025) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2025.3530461 · Cited by 11
“This approach improves the results of clinical trial participants by controlling blood sugar levels [3].”
A survey of cyber-physical system implementations of real-time personalized interventions
Steele, R. J., Hillsgrove, T., Khoshavi, N., & Jaimes, L. G. (2021) · Journal of Ambient Intelligence and Humanized Computing · doi:10.1007/s12652-021-03263-0 · Cited by 8
“An important related technology are the patches used for continuous glucose monitoring (CGM) that also involve a disposable sensor placed just below the surface of the skin to measure interstitial fluid (ISF) or tissue fluid glucose levels (Facchinetti 2016; Eadie and Steele 2017).”
BackgroundPredicting Diabetes using CNN for Various Activation Functions: A Comparative Study
Goel, S., Sharma, S., & Tripathi, R. (2021) · International Conference on System Modeling & Advancement in Research Trends (SMART) · doi:10.1109/smart52563.2021.9676280 · Cited by 12
A Personalized Week-to-Week Updating Algorithm to Improve Continuous Glucose Monitoring Performance
Zavitsanou, S., Lee, J. B., Pinsker, J. E., Church, M. M., Doyle, F. J., & Dassau, E. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817734367 · Cited by 8
Metadata
- Authors
- Facchinetti, A.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Facchinetti, Andrea
- ORCID
- Facchinetti, Andrea
- Venue
- Sensors
- Publisher
- MDPI AG
- Published
- 2016-12-09
- Volume
- 16
- Issue
- 12
- Pages
- 2093
- ISSN
- 1424-8220 (ISSN-L)
- PMC
- PMC5191073
- OpenAlex
- W2560030487
- Cited by
- 176
- References
- 68
- Citations by year
- 2026: 14 · 2025: 16 · 2024: 8 · 2023: 17 · 2022: 17 · 2021: 16 · 2020: 22 · 2019: 25 · 2018: 19 · 2017: 22
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Sensors (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Physical Sciences › Chemistry › Analytical Chemistry › Electrochemical sensors and biosensors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- continuous glucose monitoring, type 1 diabetes, glucose prediction, hypoglycemia prediction, artificial pancreas, signal processing algorithms, sensor accuracy and reliability
- MeSH terms
- Clinical Decision-Making, Algorithms, Diabetes Mellitus, Type 1, Humans, Software, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.